Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 27 Feb 2001):

Serotonin, norepinephrine and dopamine involvement in the antidepressant action of hypericum perforatum.

Full Abstract

Hypericum perforatum is considered an effective alternative to the synthetic antidepressants in the treatment of mild-to-moderate depression. Recently, we showed that the effects on neurotransmitter contents in different brain regions of laboratory animals are more evident after administration of hypericum extracts containing a higher concentration of flavonoids, thus suggesting that these compounds are important in the antidepressant action of hypericum perforatum. We studied the effects of Ph-50, a hypericum extract standardized to flavonoids (50%) and containing 0.3% hypericin and 4.5% hyperforin on brain serotonin content, norepinephrine and dopamine by a high-performance liquid chromatography method in discrete brain areas (cortex, diencephalon and brainstem) in male Sprague-Dawley rats. Moreover, we evaluated the effects of Ph-50 alone or in association with sulpiride (a dopamine receptor antagonist), metergoline (a serotonin receptor antagonist) and 6-hydroxydopamine (6-OH-DA, destroying norepinephrine-containing neurons) using a forced-swimming test in the rat. Hypericum extract (Ph-50; 250-500 mg/kg) with acute oral administration enhanced serotonin, norepinephrine and dopamine content in the brain and reduced the immobility time of rats in the forced-swimming test. Sulpiride, metergoline and 6-OH-DA significantly increased the period of immobility in the forced-swimming test for the rats receiving hypericum extract (Ph-50). The results indicate that the neurotransmitters studied could be involved in the anti-immobility effects of hypericum, and suggest that its antidepressant action is probably mediated by serotonergic, noradrenergic and dopaminergic system activation.

 

Author information

Author/s: Calapai, G (G); Crupi, A (A); Firenzuoli, F (F); Inferrera, G (G); Squadrito, F (F); Parisi, A (A); De Sarro, G (G); Caputi, A (A);

Affiliation: Institute of Pharmacology, School of Medicine, University of Messina, Torre Biologica Policlinico Universitario, Italy. gcalapai(-atsign-)unime.it

Journal and publication information

Publication Type: Journal Article

Journal: Pharmacopsychiatry (Pharmacopsychiatry), published in Germany. (Language: eng)

Reference: 2001-Mar; vol 34 (issue 2) : pp 45-9

Dates: Created 2001/04/13; Completed 2001/08/09; Revised 2003/11/14;

PMID: 11302563, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Antidepressive Agents (0) ; Antidepressive Agents, Second-Generation (0) ; Plant Extracts (0) ; Oxidopamine (1199-18-4) ; Sulpiride (15676-16-1) ; Serotonin (50-67-9) ; Norepinephrine (51-41-2) ; Dopamine (51-61-6) ; Hydroxyindoleacetic Acid (54-16-0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

7/20/2005
6/1/2008
Higher Relevance Score (21)
Lower Relevance Score (15)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index